Welcome to our dedicated page for Privia Health Group news (Ticker: PRVA), a resource for investors and traders seeking the latest updates and insights on Privia Health Group stock.
Privia Health Group operates as a U.S. physician enablement company focused on primary-care centric medical groups, risk-bearing entities and the Privia Platform of technology and service solutions. The company works with medical groups, health plans and health systems to build provider networks and support value-based care.
Company updates commonly cover quarterly and annual operating results, guidance, practice collections, care margin, platform contribution, adjusted EBITDA and provider growth. Recurring developments also include performance in value-based risk arrangements, expansion into new or existing states, material agreements, capital-structure disclosures and governance matters.
Privia Health Group, Inc. (PRVA) announced robust third-quarter results with total revenue reaching $251.5 million, a 21.4% increase year-over-year. However, the company reported a net loss of $9.1 million, or $0.09 per share, compared to a profit of $16.7 million in the same period last year. Practice collections rose to $401.5 million, and adjusted EBITDA grew by 51.9% to $13.9 million. The firm entered the California and West Texas markets, raising its full-year 2021 guidance across multiple metrics, signaling strong growth potential ahead.
Privia Health Group, Inc. (Nasdaq: PRVA), a national physician enablement company, announced its participation in three key investor conferences. The events are scheduled for November 10 at the Credit Suisse Healthcare Conference, November 18 at the Canaccord Genuity Digital Health & Services Forum, and December 1 at the Piper Sandler Healthcare Conference. Webcasts and slide presentations will be accessible via the company's investor relations website. Privia Health focuses on enhancing physician practices and patient experiences through advanced technology.
Privia Health Group, Inc. (PRVA) is expanding its national provider network by collaborating with over 430 new providers in California and Texas. This includes partnerships with BASS Medical Group in California and Abilene Diagnostic Clinic in West Texas. These ventures aim to enhance patient care and support healthcare providers in their transition to value-based care. The company plans to update its full-year 2021 guidance following its third-quarter financial results on November 8, reflecting the anticipated impact of these expansions.
Privia Health Group (Nasdaq: PRVA) is set to announce its third-quarter financial results for the period ending September 30, 2021, before market open on November 8, 2021. The financial press release will be available at ir.priviahealth.com by 7:00 am ET. Management will also hold a conference call at 8:00 am ET to discuss the results and future outlook. Interested parties can participate via a webcast or by dialing 855-940-5315.
BOSTON--(BUSINESS WIRE)--Kyruus announced that Privia Health is now using the Kyruus ProviderMatch platform to enhance patient access and streamline online appointment bookings. Privia Health serves approximately 2,700 providers and 3 million patients, aiming to improve consumer self-service and reduce administrative burdens. The integration facilitates a seamless search experience, allowing patients to find providers based on specific needs. With online scheduling activated for nearly 1,200 providers, Privia is poised for further growth in digital offerings.
Biote Medical has announced the election of Dr. Mark Cone and Dana Jacoby to its Board of Directors, strengthening its leadership team with over 60 years of combined experience in healthcare and business management. Dr. Cone is the Market President of Privia Health in South Texas, while Jacoby has led nearly $1 billion in healthcare mergers and transactions. Their appointments aim to enhance Biote's growth and address hormone deficiencies affecting over 200 million Americans.
Privia Health Group (Nasdaq: PRVA) reported impressive results for 2020, achieving $86.5 million in shared savings through its Accountable Care Organizations (ACOs) via the Medicare Shared Savings Program (MSSP). The Privia Quality Network served over 121,000 Medicare beneficiaries, demonstrating a commitment to quality care while lowering costs. Key metrics showed that Privia's expenditures were 15% lower than the median MSSP ACO and emergency room utilization was 22% lower. Since 2014, total shared savings exceed $519 million.
Privia Health Group, Inc. (Nasdaq: PRVA) reported strong revenue growth in Q2 2021, with total revenue climbing to $225.8 million, a 23.2% increase year-over-year. However, the company faced significant operating and net losses of $193.2 million and $172.5 million, respectively, mainly due to $202.6 million in non-cash stock compensation expense related to its IPO. Excluding these, non-GAAP adjusted net income increased 69.0% to $10.4 million. The company expects continued growth with increased provider partnerships and attributed lives, revising its full-year guidance upwards.
Privia Health Group (Nasdaq: PRVA) has announced its financial results release for the second quarter ended June 30, 2021, scheduled for August 9, 2021, before market open. The financial results will be available at 7:00 am ET on the company's Investor Relations website. Additionally, a conference call will follow at 8:00 am ET the same day to discuss the results and future outlook. Interested parties can access the call via webcast or by dialing 855-940-5315.
Health Enterprise Partners (HEP) announced five realizations of portfolio companies and a new investment in Kno2, marking its tenth platform investment from HEP III. HEP focuses on founder-financed businesses, having previously invested in Twistle, which enhances patient engagement in healthcare. Health Catalyst (NASDAQ: HCAT) disclosed its acquisition of Twistle, enhancing its data and analytics services. Privia Health (NASDAQ: PRVA) completed a successful IPO, raising approximately $131.7 million. HEP's new investment in Kno2 will support interoperability in healthcare, aiming for better patient information exchange.